Groeneveld DJ - Search Results

1

Biogenesis of Weibel-Palade bodies in von Willebrand's disease variants with impaired von Willebrand factor intrachain or interchain disulfide bond formation.

Wang JW, Groeneveld DJ, Cosemans G, Dirven RJ, Valentijn KM, Voorberg J, Reitsma PH, Eikenboom J. Wang JW, et al. Among authors: groeneveld dj. Haematologica. 2012 Jun;97(6):859-66. doi: 10.3324/haematol.2011.057216. Epub 2011 Dec 29. Haematologica. 2012. PMID: 22207689 Free PMC article.

2

No evidence for a direct effect of von Willebrand factor's ABH blood group antigens on von Willebrand factor clearance.

Groeneveld DJ, van Bekkum T, Cheung KL, Dirven RJ, Castaman G, Reitsma PH, van Vlijmen B, Eikenboom J. Groeneveld DJ, et al. J Thromb Haemost. 2015 Apr;13(4):592-600. doi: 10.1111/jth.12867. Epub 2015 Mar 11. J Thromb Haemost. 2015. PMID: 25650553 Free article.

3

Angiogenic characteristics of blood outgrowth endothelial cells from patients with von Willebrand disease.

Groeneveld DJ, van Bekkum T, Dirven RJ, Wang JW, Voorberg J, Reitsma PH, Eikenboom J. Groeneveld DJ, et al. J Thromb Haemost. 2015 Oct;13(10):1854-66. doi: 10.1111/jth.13112. Epub 2015 Sep 21. J Thromb Haemost. 2015. PMID: 26270243 Free article.

4

Storage and secretion of naturally occurring von Willebrand factor A domain variants.

Groeneveld DJ, Wang JW, Mourik MJ, Dirven RJ, Valentijn KM, Voorberg J, Reitsma PH, Eikenboom J. Groeneveld DJ, et al. Br J Haematol. 2014 Nov;167(4):529-40. doi: 10.1111/bjh.13074. Epub 2014 Aug 8. Br J Haematol. 2014. PMID: 25103891 Free article.

5

von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease.

Sanders YV, Groeneveld D, Meijer K, Fijnvandraat K, Cnossen MH, van der Bom JG, Coppens M, de Meris J, Laros-van Gorkom BA, Mauser-Bunschoten EP, Leebeek FW, Eikenboom J; WiN study group. Sanders YV, et al. Blood. 2015 May 7;125(19):3006-13. doi: 10.1182/blood-2014-09-603241. Epub 2015 Feb 11. Blood. 2015. PMID: 25673639 Free article.

6

Circulating Angiogenic Mediators in Patients with Moderate and Severe von Willebrand Disease: A Multicentre Cross-Sectional Study.

Groeneveld DJ, Sanders YV, Adelmeijer J, Mauser-Bunschoten EP, van der Bom JG, Cnossen MH, Fijnvandraat K, Laros-van Gorkom BAP, Meijer K, Lisman T, Eikenboom J, Leebeek FWG. Groeneveld DJ, et al. Thromb Haemost. 2018 Jan;118(1):152-160. doi: 10.1160/TH17-06-0397. Epub 2018 Jan 5. Thromb Haemost. 2018. PMID: 29304535

7

Balance between von Willebrand factor and ADAMTS13 following major partial hepatectomy.

Groeneveld DJ, Alkozai EM, Adelmeijer J, Porte RJ, Lisman T. Groeneveld DJ, et al. Br J Surg. 2016 May;103(6):735-743. doi: 10.1002/bjs.10107. Epub 2016 Mar 23. Br J Surg. 2016. PMID: 27005894

8

Targeting von Willebrand factor in liver diseases: A novel therapeutic strategy?

Groeneveld DJ, Poole LG, Luyendyk JP. Groeneveld DJ, et al. J Thromb Haemost. 2021 Jun;19(6):1390-1408. doi: 10.1111/jth.15312. Epub 2021 May 3. J Thromb Haemost. 2021. PMID: 33774926 Free PMC article. Review.

9

Von Willebrand factor deficiency reduces liver fibrosis in mice.

Joshi N, Kopec AK, Ray JL, Cline-Fedewa H, Groeneveld DJ, Lisman T, Luyendyk JP. Joshi N, et al. Among authors: groeneveld dj. Toxicol Appl Pharmacol. 2017 Aug 1;328:54-59. doi: 10.1016/j.taap.2017.05.018. Epub 2017 May 17. Toxicol Appl Pharmacol. 2017. PMID: 28527913 Free PMC article.

10

Von Willebrand factor delays liver repair after acetaminophen-induced acute liver injury in mice.

Groeneveld D, Cline-Fedewa H, Baker KS, Williams KJ, Roth RA, Mittermeier K, Lisman T, Palumbo JS, Luyendyk JP. Groeneveld D, et al. J Hepatol. 2020 Jan;72(1):146-155. doi: 10.1016/j.jhep.2019.09.030. Epub 2019 Oct 10. J Hepatol. 2020. PMID: 31606553 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page